Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)The Safety and Tolerability of STSA-1005 Following Intravenous Infusion in Healthy Subjects
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- Drug: STSA-1005 injectionDrug: Placebo
- First Posted Date
- 2021-10-20
- Last Posted Date
- 2022-04-18
- Lead Sponsor
- Staidson Biopharma Inc.
- Target Recruit Count
- 32
- Registration Number
- NCT05085197
- Locations
- 🇺🇸
AltaSciences Clinical Kansas, Inc, Overland Park, Kansas, United States
News
No news found